Why Invest With Us?

Medicinal Organic Cannabis Australia (MOCA) Pty Ltd (ACN: 619 709 278) are offering up to 500,000 fully-paid ordinary shares at $1 per share to raise a maximum of $500,000. This Offer is made under the CSF regime in Part 6D.3A of the Corporations Act 2001 (Corporations Act).

The general public in Australia can buy up to $10,000 worth of shares in this company, as part of the new equity crowdfunding legislation (Note: there is no cap on how much Sophisticated Investors can invest). 

You can make your investment on this link up until October 21st 2020 or until fully subscribed.

Please make sure to read the risk warning statement, offer document, and understand the Cooling-Off rights. Instructions on how to register to invest and pledge are here.

Summary of Key Points

Medicinal Organic Cannabis Australia (MOCA) is the first established organic cannabis company in Australia, with a focus on ethically sourced organic products.

Licenced: Australian import, export and wholesale licences for Medical Cannabis. European approvals and subsidies to cultivate in Europe

Products Approved: 21 products approved in Australia by the TGA

Import Permits: Australian import permits from the Office of Drug Control for all its products.

Products: has an approved range of MOCA branded organic cannabis products & has developed a new product that could reduce patient costs by 30%

Distribution: has supply agreements with pharmacies and practitioners in Australia.

Team: is science based with 4 PhD’s on the team to ensure product quality and standard. MOCA is focused on leveraging digital marketing channels. Has global third party warehousing and logistics suppliers in Australia.

International opportunities: were finalists in 2 international tenders to supply cannabis (Italy & Barbados)

Facilities: has a 15 year lease on a 18,000m2 cultivation facility in Italy with subsidised water and energy costs.

About Us

Medicinal Organic Cannabis Australia (MOCA) Pty Ltd was founded in March 2017 and incorporated in June 2017. Australian State and Federal medical cannabis import, export and wholesale licences were awarded to MOCA in 2018.

Directors, Alessandro Sorbello and Emanuela Ispani, founded the Company following changes to Australian legislation. The directors commenced with scientific research to develop MOCA’s product range. MOCA now has four PhD’s on the team and has converted its knowledge base to develop a product range of 21 organic medicines. Ten products developed by our scientific team under the MOCA brand and 11 products sourced from third party manufacturers, including CBDfx and Stanley Brothers.

All our products are approved by the Australian Government (TGA) and can be prescribed by medical practitioners to treat a range of conditions including:

- chronic pain

- anxiety

- chemotherapy-induced nausea and vomiting

- epilepsy

- palliative care indications

- cancer pain

- spasticity from neurological conditions

- anorexia and other conditions.

The three key gateways to importing and supplying medical cannabis medicines by wholesale in Australia are:

- State and Federal Government licenses to import and wholesale

- Import permits from the Office of Drug Control (ODC)

- Product approvals by the TGA

MOCA has all three gateways approved with licences, permits and approvals in hand.

We are equity crowd-sourced funding to manufacture our products and import into Australia for immediate sale. Once our products are manufactured and ready for import, MOCA’s innovative stock management and distribution model kicks in.

In conjunction with international standards, MOCA has developed proprietary production and manufacturing protocols and procedures. These operational methods of operation are approved at State and Federal level by the New South Wales Ministry of Health and the Office of Drug Control (ODC). They are designed to manage and meet its extensive regulatory compliance for the storage and handling of medical cannabis products.

These protocols mean that MOCA is ‘hands free’ and our entire process for transport, storage and distribution of our products are handled by Specialised global pharmaceutical contractors in their logistics centre. This process eliminates the need for expensive proprietary warehousing costs and logistics staff, thus significantly reducing the Company’s operating costs to supply the products to medical professionals.

At Medicinal Organic Cannabis Australia (MOCA), each cannabis flower is given the care it deserves at the hands of a passionate team that strives to ensure medical cannabis is available to everyone who needs it.

MOCA is growing and growing fast!! We are currently a privately held company offering a series of investment opportunities.

Thank you for your interest in investing in our Company and in helping grow the best organic cannabis company in the world. 

Location

New Zealand

MOCA Pty Ltd - Registered Office: Kensignton Swan, 18 Viaduct Harbour, Auckland Central. Auckland 1010, New Zealand 

Address

Medicinal Organic Cannabis Australia (MOCA Pty Ltd Registered Office - Unit 903, 50 Clarence Street, Sydney NSW 2000 Australia.

Contact us

Connect with us